Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1918-2026

Rover Mobile X-ray System Recall

Rover Mobile X-ray System Model/Catalog Number: MXU-RV35 and MXU-RV71

FDA recall Class II

Ongoing

FDA lists this Class II recall for Rover Mobile X-ray System. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1918-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 27, 2026
FDA report date
Apr 29, 2026
Quantity in commerce
32 units
Distribution
See key details
FDA cause
Component design/selection

What is being recalled?

Rover Mobile X-ray System Model/Catalog Number: MXU-RV35 and MXU-RV71

Affected model & UDI checker

Search the exact identifiers published for Z-1918-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
MXU-RV35Rover Mobile X-ray SystemCheck source noticeNot specified
MXU-RV71Rover Mobile X-ray SystemCheck source noticeNot specified
Not specifiedRover Mobile X-ray SystemCheck source notice09357123000051
Not specifiedRover Mobile X-ray SystemCheck source notice09357123000037
FDA code information

Lot Code: Refer to product traceability spreadsheet provided MXU-RV71 UDI: (01)09357123000051/ Serial Numbers: 334 397 399 408 423 425 459 MXU-RV35 UDI: (01)09357123000037/ Serial Numbers: 269 223 349 348 351 363 388 384 391 359 416 419 428 429 430 431 435 434 436 413 437 438 460 461 462

View the original FDA recall notice

Why was this product recalled?

X-Ray generator may malfunction resulting in the X-Ray being inoperable.

What actions did Micro-X Ltd. take?

On March 27, 2026, Micro-X issued a Urgent: Medical Device Correction Notification, via E-Mail. Micro-X ask consignees to take the following actions: " Contact your local service representative to arrange replacement of the PCBA with the updated version at the next scheduled visit or Preventative Maintenance. In the interim, customers may continue to use the device. " To minimize the likelihood of system failure, the batteries should not be permitted to fully discharge. Any system errors or abnormal behaviours must be reported to your authorised service provider without delay. " If the product has been further distributed to other facilities, please ensure this notice is immediately shared with them. " Please complete and email the Customer Response Form in Appendix 1 to the Micro-X LTD in Australia: [email protected] and copy [email protected] Completing this form confirms receipt of this notice, understanding of the issue, and the necessary actions to be taken.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology